| 1 | [SID103192063] | Active | Ki | 0.01 | Inhibition of human carbonic anhydrase 4 by stopped flow CO2 hydration method [AID496916, Type: Literature] | Carbonic anhydrase 4 [gi:115465] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 0.01 [uM] | | BioAssay | Inhibition of human carbonic anhydrase 4 by stopped flow CO2 hydration method | | AID | 496916 | | BioAssay type | Literature | | Target | Carbonic anhydrase 4 [gi:115465] | | PubMed | 20590092 | | Data Table |  |
|
| 2 | [SID103192063] | Active | Ki | 0.2 | Inhibition of [3H]spermine transport by the compound was evaluated in ZR-75-1 human breast cancer cells [AID220401, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 0.2 [uM] | | BioAssay | Inhibition of [3H]spermine transport by the compound was evaluated in ZR-75-1 human breast cancer cells | | AID | 220401 | | BioAssay type | Literature | | Target | | | PubMed | 10397506 | | Data Table |  |
|
| 3 | [SID103192063] | Active | Ki | 0.28 | Inhibition of [3H]spermidine transport into MDA-MB-231 (human breast cancer) cells. [AID101790, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 0.28 [uM] | | BioAssay | Inhibition of [3H]spermidine transport into MDA-MB-231 (human breast cancer) cells. | | AID | 101790 | | BioAssay type | Literature | | Target | | | PubMed | 11606128 | | Data Table |  |
|
| 4 | [SID103192063] | Active | IC50 | 0.39 | Compound was tested for inhibitory concentration required to inhibit 50% of [14C]- putrescine uptake. [AID101071, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | IC50 | 0.39 [uM] | | BioAssay | Compound was tested for inhibitory concentration required to inhibit 50% of [14C]- putrescine uptake. | | AID | 101071 | | BioAssay type | Literature | | Target | | | PubMed | 9871574 | | Data Table |  |
|
| 5 | [SID103192063] | Active | Ki | 0.65 | Inhibition of [3H]putrescine transport by the compound was evaluated in T-47D human breast cancer cells [AID210101, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 0.65 [uM] | | BioAssay | Inhibition of [3H]putrescine transport by the compound was evaluated in T-47D human breast cancer cells | | AID | 210101 | | BioAssay type | Literature | | Target | | | PubMed | 10397506 | | Data Table |  |
|
| 6 | [SID103192063] | Active | Ki | 0.71 | Inhibition of human carbonic anhydrase 7 by stopped flow CO2 hydration method [AID496920, Type: Literature] | Carbonic anhydrase 7 [gi:1168744] |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 0.71 [uM] | | BioAssay | Inhibition of human carbonic anhydrase 7 by stopped flow CO2 hydration method | | AID | 496920 | | BioAssay type | Literature | | Target | Carbonic anhydrase 7 [gi:1168744] | | PubMed | 20590092 | | Data Table |  |
|
| 7 | [SID103192063] | Active | Ki | 0.83 | Inhibition of human carbonic anhydrase 5B by stopped flow CO2 hydration method [AID496918, Type: Literature] | Carbonic anhydrase 5B, mitochondrial [gi:8928041] |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 0.83 [uM] | | BioAssay | Inhibition of human carbonic anhydrase 5B by stopped flow CO2 hydration method | | AID | 496918 | | BioAssay type | Literature | | Target | Carbonic anhydrase 5B, mitochondrial [gi:8928041] | | PubMed | 20590092 | | Data Table |  |
|
| 8 | [SID103192063] | Active | Ki | 0.84 | Inhibition of human carbonic anhydrase 5A by stopped flow CO2 hydration method [AID496917, Type: Literature] | Carbonic anhydrase 5A, mitochondrial [gi:461680] |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 0.84 [uM] | | BioAssay | Inhibition of human carbonic anhydrase 5A by stopped flow CO2 hydration method | | AID | 496917 | | BioAssay type | Literature | | Target | Carbonic anhydrase 5A, mitochondrial [gi:461680] | | PubMed | 20590092 | | Data Table |  |
|
| 9 | [SID103192063] | Active | Ki | 0.86 | Inhibition of human carbonic anhydrase 14 by stopped flow CO2 hydration method [AID496924, Type: Literature] | Carbonic anhydrase 14 [gi:8928036] |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 0.86 [uM] | | BioAssay | Inhibition of human carbonic anhydrase 14 by stopped flow CO2 hydration method | | AID | 496924 | | BioAssay type | Literature | | Target | Carbonic anhydrase 14 [gi:8928036] | | PubMed | 20590092 | | Data Table |  |
|
| 10 | [SID103192063] | Active | Ki | 0.92 | Inhibition of [3H]spermidine transport by the compound was evaluated in T-47D human breast cancer cells [AID210103, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 0.92 [uM] | | BioAssay | Inhibition of [3H]spermidine transport by the compound was evaluated in T-47D human breast cancer cells | | AID | 210103 | | BioAssay type | Literature | | Target | | | PubMed | 10397506 | | Data Table |  |
|
| 11 | [SID103192063] | Active | Ki | 0.99 | Inhibition of human carbonic anhydrase 6 by stopped flow CO2 hydration method [AID496919, Type: Literature] | Carbonic anhydrase 6 [gi:116241278] |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 0.99 [uM] | | BioAssay | Inhibition of human carbonic anhydrase 6 by stopped flow CO2 hydration method | | AID | 496919 | | BioAssay type | Literature | | Target | Carbonic anhydrase 6 [gi:116241278] | | PubMed | 20590092 | | Data Table |  |
|
| 12 | [SID103192063] | Active | Ki | 1.34 | Inhibition of [14C]spermidine uptake at polyamine transport system in mouse L1210 cells after 10 mins [AID536842, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 1.34 [uM] | | BioAssay | Inhibition of [14C]spermidine uptake at polyamine transport system in mouse L1210 cells after 10 mins | | AID | 536842 | | BioAssay type | Literature | | Target | | | PubMed | 20925391 | | Data Table |  |
|
| 13 | [SID103192063] | Active | Ki | 1.34 | Binding affinity to the mouse polyamine transporter on the L1210 cell surface [AID160317, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 1.34 [uM] | | BioAssay | Binding affinity to the mouse polyamine transporter on the L1210 cell surface | | AID | 160317 | | BioAssay type | Literature | | Target | | | PubMed | 12801231 | | Data Table |  |
|
| 14 | [SID103192063] | Active | ED50 | 2 | Effective dose required for binding to lipopolysaccharide using Fluorescence Displacement Assay; Range is ~1-2 uM [AID240418, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | ED50 | 2 [uM] | | BioAssay | Effective dose required for binding to lipopolysaccharide using Fluorescence Displacement Assay; Range is ~1-2 uM | | AID | 240418 | | BioAssay type | Literature | | Target | | | PubMed | 15801849 | | Data Table |  |
|
| 15 | [SID103192063] | Active | Km | 2 | Michaelis menton constant of compound was determined at MDA-MB-231 cell line mediated by polyamine transporter [AID162587, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Km | 2 [uM] | | BioAssay | Michaelis menton constant of compound was determined at MDA-MB-231 cell line mediated by polyamine transporter | | AID | 162587 | | BioAssay type | Literature | | Target | | | PubMed | 11738568 | | Data Table |  |
|
| 16 | [SID103192063] | Active | Ki | 2.1 | Inhibition of spermidine transport determined in T-47D human breast cancer cells [AID210118, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 2.1 [uM] | | BioAssay | Inhibition of spermidine transport determined in T-47D human breast cancer cells | | AID | 210118 | | BioAssay type | Literature | | Target | | | PubMed | 12951106 | | Data Table |  |
|
| 17 | [SID103192063] | Active | Ki | 2.7 | Inhibition of [3H]spermine transport by the compound was evaluated in T-47D human breast cancer cells [AID210105, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 2.7 [uM] | | BioAssay | Inhibition of [3H]spermine transport by the compound was evaluated in T-47D human breast cancer cells | | AID | 210105 | | BioAssay type | Literature | | Target | | | PubMed | 10397506 | | Data Table |  |
|
| 18 | [SID103192063] | Active | IC50 | 2.8 | Ability to displace ethidium bromide from double stranded synthetic Poly (dA-dT) [AID162413, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | IC50 | 2.8 [uM] | | BioAssay | Ability to displace ethidium bromide from double stranded synthetic Poly (dA-dT) | | AID | 162413 | | BioAssay type | Literature | | Target | | | PubMed | 1875339 | | Data Table |  |
|
| 19 | [SID103192063] | Active | IC50 | 3 | Concentration required to decrease the fluorescence of the ethidium bromide-calf thymus DNA complex by 50% [AID54446, Type: other] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | IC50 | 3 [uM] | | BioAssay | Concentration required to decrease the fluorescence of the ethidium bromide-calf thymus DNA complex by 50% | | AID | 54446 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID103192063] | Active | IC50 | 4.3 | Ability to displace ethidium bromide from calf thymus DNA [AID54444, Type: Literature] | |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | IC50 | 4.3 [uM] | | BioAssay | Ability to displace ethidium bromide from calf thymus DNA | | AID | 54444 | | BioAssay type | Literature | | Target | | | PubMed | 1875339 | | Data Table |  |
|
| 21 | [SID90341642] | Active | Potency | 4.6109 | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF [AID624455, Type: confirmatory] | dopamine D1 receptor [Homo sapiens] [gi:299681] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 90341642 | | CID | 1103 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF | | AID | 624455 | | BioAssay type | confirmatory | | Target | dopamine D1 receptor [Homo sapiens] [gi:299681] | | PubMed | | | Data Table |  |
|
| 22 | [SID90341642] | Active | Potency | 4.6109 | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF [AID624455, Type: confirmatory] | dopamine D1 receptor [Homo sapiens] [gi:299681] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 90341642 | | CID | 1103 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF | | AID | 624455 | | BioAssay type | confirmatory | | Target | dopamine D1 receptor [Homo sapiens] [gi:299681] | | PubMed | | | Data Table |  |
|
| 23 | [SID90341642] | Active | Potency | 4.6109 | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF [AID624455, Type: confirmatory] | dopamine D1 receptor [Homo sapiens] [gi:299681] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 90341642 | | CID | 1103 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF | | AID | 624455 | | BioAssay type | confirmatory | | Target | dopamine D1 receptor [Homo sapiens] [gi:299681] | | PubMed | | | Data Table |  |
|
| 24 | [SID90341642] | Active | Potency | 4.6109 | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF [AID624455, Type: confirmatory] | dopamine D1 receptor [Homo sapiens] [gi:299681] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 90341642 | | CID | 1103 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF | | AID | 624455 | | BioAssay type | confirmatory | | Target | dopamine D1 receptor [Homo sapiens] [gi:299681] | | PubMed | | | Data Table |  |
|
| 25 | [SID103192063] | Active | EC50 | 5.2 | Ability to enhance [3H]MK-801 binding to NMDA receptors in rat forebrain membranes was calculated with respect to spermine [AID144318, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | EC50 | 5.2 [uM] | | BioAssay | Ability to enhance [3H]MK-801 binding to NMDA receptors in rat forebrain membranes was calculated with respect to spermine | | AID | 144318 | | BioAssay type | Literature | | Target | | | PubMed | 8523402 | | Data Table |  |
|
| 26 | [SID103192063] | Active | IC50 | 6 | Ability to displace ethidium bromide from double stranded synthetic poly (dG-dC) [AID162553, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | IC50 | 6 [uM] | | BioAssay | Ability to displace ethidium bromide from double stranded synthetic poly (dG-dC) | | AID | 162553 | | BioAssay type | Literature | | Target | | | PubMed | 1875339 | | Data Table |  |
|
| 27 | [SID103192063] | Active | CC50 | 6.8 | Drug concentration required to produce 50% inhibition of fluorescence bound ethidium to CT-DNA (1.26:1) (+/-SEM 5%) [AID220346, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | CC50 | 6.8 [uM] | | BioAssay | Drug concentration required to produce 50% inhibition of fluorescence bound ethidium to CT-DNA (1.26:1) (+/-SEM 5%) | | AID | 220346 | | BioAssay type | Literature | | Target | | | PubMed | 12408721 | | Data Table |  |
|
| 28 | [SID11113818] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19 [AID899, Type: confirmatory] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 11113818 | | CID | 1103 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19 | | AID | 899 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 29 | [SID11113818] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19 [AID899, Type: confirmatory] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 11113818 | | CID | 1103 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19 | | AID | 899 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 30 | [SID103192063] | Active | EC50 | 8.5 | Activation of procaspase 2 after 24 hrs [AID328670, Type: Literature] | |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | EC50 | 8.5 [uM] | | BioAssay | Activation of procaspase 2 after 24 hrs | | AID | 328670 | | BioAssay type | Literature | | Target | | | PubMed | 18366176 | | Data Table |  |
|
| 31 | [SID90341642] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 90341642 | | CID | 1103 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 32 | [SID103192063] | Active | Ki | 13.3 | Inhibition of human carbonic anhydrase 9 by stopped flow CO2 hydration method [AID496921, Type: Literature] | Carbonic anhydrase 9 [gi:83300925] |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 13.3 [uM] | | BioAssay | Inhibition of human carbonic anhydrase 9 by stopped flow CO2 hydration method | | AID | 496921 | | BioAssay type | Literature | | Target | Carbonic anhydrase 9 [gi:83300925] | | PubMed | 20590092 | | Data Table |  |
|
| 33 | [SID103192063] | Active | Ki | 13.3 | Inhibition of human carbonic anhydrase 9 preincubated for 15 mins by CO2 hydration stopped-flow assay [AID568364, Type: Literature] | Carbonic anhydrase 9 [gi:83300925] |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 13.3 [uM] | | BioAssay | Inhibition of human carbonic anhydrase 9 preincubated for 15 mins by CO2 hydration stopped-flow assay | | AID | 568364 | | BioAssay type | Literature | | Target | Carbonic anhydrase 9 [gi:83300925] | | PubMed | 21282059 | | Data Table |  |
|
| 34 | [SID103192063] | Active | IC50 | 17 | Binding of compound to calf thymus DNA was determined by an ethidium bromide displacement assay [AID46156, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | IC50 | 17 [uM] | | BioAssay | Binding of compound to calf thymus DNA was determined by an ethidium bromide displacement assay | | AID | 46156 | | BioAssay type | Literature | | Target | | | PubMed | 9397169 | | Data Table |  |
|
| 35 | [SID103192063] | Active | Ki | 22.6 | Inhibition of mouse carbonic anhydrase 13 by stopped flow CO2 hydration method [AID496923, Type: Literature] | Carbonic anhydrase 13 [gi:30580372] |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 22.6 [uM] | | BioAssay | Inhibition of mouse carbonic anhydrase 13 by stopped flow CO2 hydration method | | AID | 496923 | | BioAssay type | Literature | | Target | Carbonic anhydrase 13 [gi:30580372] | | PubMed | 20590092 | | Data Table |  |
|
| 36 | [SID103192063] | Active | Ki | 27.6 | Inhibition of human carbonic anhydrase 12 by stopped flow CO2 hydration method [AID496922, Type: Literature] | Carbonic anhydrase 12 [gi:5915866] |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 27.6 [uM] | | BioAssay | Inhibition of human carbonic anhydrase 12 by stopped flow CO2 hydration method | | AID | 496922 | | BioAssay type | Literature | | Target | Carbonic anhydrase 12 [gi:5915866] | | PubMed | 20590092 | | Data Table |  |
|
| 37 | [SID103192063] | Active | Ki | 27.6 | Inhibition of human carbonic anhydrase 12 preincubated for 15 mins by CO2 hydration stopped-flow assay [AID568365, Type: Literature] | Carbonic anhydrase 12 [gi:5915866] |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | Ki | 27.6 [uM] | | BioAssay | Inhibition of human carbonic anhydrase 12 preincubated for 15 mins by CO2 hydration stopped-flow assay | | AID | 568365 | | BioAssay type | Literature | | Target | Carbonic anhydrase 12 [gi:5915866] | | PubMed | 21282059 | | Data Table |  |
|
| 38 | [SID11113818] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_1, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 11113818 | | CID | 1103 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 39 | [SID11113818] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 11113818 | | CID | 1103 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 40 | [SID11113818] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_1, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 11113818 | | CID | 1103 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 41 | [SID11113818] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 11113818 | | CID | 1103 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 42 | [SID11113818] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 11113818 | | CID | 1103 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 43 | [SID85209806] | Active | | | Ligands of Class C GPCRs [AID2059, Type: other] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 85209806 | | CID | 1103 | | Outcome | Active | | BioAssay | Ligands of Class C GPCRs | | AID | 2059 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID103192063] | Active | | | Activation of chymotrypsin after 30 mins [AID328671, Type: Literature] | |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | BioAssay | Activation of chymotrypsin after 30 mins | | AID | 328671 | | BioAssay type | Literature | | Target | | | PubMed | 18366176 | | Data Table |  |
|
| 45 | [SID103192063] | Active | | | Activation of caspase 3 after 30 mins [AID328681, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | BioAssay | Activation of caspase 3 after 30 mins | | AID | 328681 | | BioAssay type | Literature | | Target | | | PubMed | 18366176 | | Data Table |  |
|
| 46 | [SID103192063] | Active | | | Growth inhibition of Escherichia coli K12 at 1 mM measured by growth curve [AID325459, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | BioAssay | Growth inhibition of Escherichia coli K12 at 1 mM measured by growth curve | | AID | 325459 | | BioAssay type | Literature | | Target | | | PubMed | 17438056 | | Data Table |  |
|
| 47 | [SID103192063] | Active | | | Growth inhibition of Escherichia coli K10 at 2 to 4 mM measured by growth curve [AID325460, Type: Literature] | |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | BioAssay | Growth inhibition of Escherichia coli K10 at 2 to 4 mM measured by growth curve | | AID | 325460 | | BioAssay type | Literature | | Target | | | PubMed | 17438056 | | Data Table |  |
|
| 48 | [SID103192063] | Active | | | Growth inhibition of Salmonella enterica serovar Typhimurium LT2 at 2 to 4 mM measured by growth curve [AID325461, Type: Literature] | |   View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103192063 | | CID | 1103 | | Outcome | Active | | BioAssay | Growth inhibition of Salmonella enterica serovar Typhimurium LT2 at 2 to 4 mM measured by growth curve | | AID | 325461 | | BioAssay type | Literature | | Target | | | PubMed | 17438056 | | Data Table |  |
|